Literature DB >> 265741

Anthracycline cardiotoxicity and acute myelogenous leukaemia.

S A Al-Ismail, D H Parry, J A Whittaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 265741      PMCID： PMC1606143          DOI： 10.1136/bmj.1.6064.815

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

Review 1.  Adriamycin. A new anticancer drug with significant clinical activity.

Authors:  R H Blum; S K Carter
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

2.  Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

Authors:  R S Benjamin; P H Wiernik; N R Bachur
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

3.  The immunotherapy of acute myelogenous leukaemia using intravenous BCG.

Authors:  J A Whittaker; A J Slater
Journal:  Br J Haematol       Date:  1977-02       Impact factor: 6.998
  3 in total
  1 in total

1.  Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.

Authors:  S Al-Ismail; J A Whittaker
Journal:  Br Med J       Date:  1979-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.